Physician assessment of asthma control in patients receiving omalizumab in a real-world setting

被引：0
|
作者：
Szabo, Melinda [1 ]
Chlumsky, Jan [2 ]
Maykut, Robert [3 ]
Georgiou, Panayiotis [4 ]
Chen, Chien-Wei [5 ]
Peachey, Guy [4 ]
机构：
[1] Koch Robert Hosp, Pulmonol, Edeleny, Hungary
[2] Charles Univ Prague, Pulm Dis, Thomayer Hosp, Prague, Czech Republic
[3] Novartis Pharma AG, Crit Care, Basel, Switzerland
[4] Novartis Pharmaceut UK Ltd, Crit Care, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Crit Care, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Asthma; -; management; Pharmacology; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
5043
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Braunstahl, Gert-Jan
    Chlumsky, Jan
    Peachey, Guy
    Chen, Chien-Wei
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [2] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Gert-Jan Braunstahl
    Jan Chlumský
    Guy Peachey
    Chien-Wei Chen
    [J]. Allergy, Asthma & Clinical Immunology, 9
  • [3] An Assessment of Asthma Control in a Real-World Setting
    Holguin, F.
    Hanania, N. A.
    Pennington, E. J.
    Busse, W. W.
    Chiddarwar, H.
    Zigmont, E.
    Chornak, J.
    Nelson, G.
    Ortega, H.
    Camargo, C. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] REDUCTIONS IN EXACERBATIONS IN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA RECEIVING OMALIZUMAB IN A REAL-WORLD SETTING
    Kuo, H. P.
    Canvin, J.
    Maykut, R.
    Bruce, J.
    Chen, C. W.
    Braunstahl, G. J.
    [J]. RESPIROLOGY, 2012, 17 : 11 - 11
  • [5] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [6] A REAL-WORLD ASSESSMENT OF OMALIZUMAB TREATMENT PATTERNS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [7] LAPSES IN ASTHMA CONTROL IN PATIENTS WHO CONTINUED VS. DISCONTINUED OMALIZUMAB IN A REAL-WORLD SETTING.
    Sun, G.
    Antonova, E.
    Chang, E.
    Broder, M.
    Solari, P.
    Zazzali, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A47 - A47
  • [8] Efficacy of Omalizumab in a real-world setting
    Sussman, Robert
    [J]. CHEST, 2007, 132 (04) : 512S - 512S
  • [9] Omalizumab in the real-world: systematic review of asthma control outcomes reported by patients
    Nissen, Francis
    Humbert, Marc
    Gibson, Peter
    Kostikas, Konstantinos
    Jaumont, Xavier
    Olsson, Petter
    Alvares, Luisa
    Bousquet, Jean
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] Reductions in exacerbations with omalizumab in a real-world setting
    Braunstahl, Gert-Jan
    Georgiou, Andreas
    Canvin, Janice
    Maykut, Robert
    Bruce, Jennifer
    Chen, Chien-Wei
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345